Abstract
The emergence of orthopedic tissue engineering devices as viable clinical solutions demands that the field address significant clinical complications associated with the implantation of foreign materials in the body, especially infection. While tissue engineering has focused on the development of methods to regenerate and repair, until recently there has been a relative dearth of literature regarding the intersection of tissue engineering and infection. In particular, local delivery of antimicrobials has long been of clinical interest, but only recently has that been translated into the realm of tissue engineering. In this perspective, we briefly review major modes of local delivery for infection prevention and treatment and discuss possible strategies for preventing implant-associated infections.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Moyad T F, Thornhill T, Estok D. Evaluation and management of the infected total hip and knee. Orthopedics, 2008, 31: 581–590
Hanssen A D, Rand J A. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect, 1999, 48: 111–122
Scott R D. National Center for Preparedness, Detection, and Control of Infectious Diseases (Centers for Disease Control and Prevention). Division of Healthcare Quality Promotion. The direct medical costs of healthcare-associated infections in US. hospitals and the benefits of prevention, 2009
Gristina A G. Biomaterial-centered infection: Microbial adhesion versus tissue integration. Science, 1987, 237: 1588–1595
Gristina A G, Shibata Y, Giridhar G, et al. The glycocalyx, biofilm, microbes, and resistant infection. Semin Arthroplasty, 1994, 5: 160–170
Bayston R, Ashraf W, Barker-Davies R, et al. Biofilm formation by propionibacterium acnes on biomaterials in vitro and in vivo: Impact on diagnosis and treatment. J Biomed Mater Res, 2007, 81A: 705–709
Spellberg B, Guidos R, Gilbert D, et al. The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis, 2008, 46: 155–164
Somayaji S N, Ritchie S, Sahraei M, et al. Staphylococcus aureus induces expression of receptor activator of NF-B ligand and prostaglandin E2 in infected murine osteoblasts. Infect Immun, 2008, 76: 5120–5126
Tabel G, Hoa N T, Tarnawski A, et al. Helicobacter pylori infection inhibits healing of the wounded duodenal epithelium in vitro. J Lab Clin Med, 2003, 142: 421–430
Schierle C F, De la Garza M, Mustoe T A, et al. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen, 2009, 17: 354–359
Guo S, DiPietro L A. Factors affecting wound healing. J Dent Res, 2010, 89: 219–229
Bost K L, Ramp W K, Nicholson N C, et al. Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production. J Infect Dis, 1999, 180: 1912–1920
Penn-Barwell J G, Murray C K, Wenke J C. Early antibiotics and debridement independently reduce infection in an open fracture model. J Bone Joint Surg Br Vol, 2012, 94B: 107–112
Koyonos L, Zmistowski B, Della Valle C J, et al. Infection control rate of irrigation and débridement for periprosthetic joint infection. Clin Orthop Rel Res, 2011, 469: 3043–3048
Odum S M, Fehring T K, Lombardi A V, et al. Irrigation and debridement for periprosthetic infections. J Arthroplasty, 2011, 26: 114–118
Fehring T K, Odum S M, Berendm K R, et al. Failure of irrigation and débridement for early postoperative periprosthetic infection. Clin Orthop Rel Res, 2013, 471: 250–257
Rathbone C R, Cross J D, Brown K V, et al. Effect of various concentrations of antibiotics on osteogenic cell viability and activity. J Orthop Res, 2011, 29: 1070–1074
Wachol-Drewek Z Z, Pfeiffer M M, Schol E E. Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin. Biomaterials, 1996, 17: 1733–1738
Noel S P, Courtney H, Bumgardner J D, et al. Chitosan films: A potential local drug delivery system for antibiotics. Clin Orthop Rel Res, 2008, 466: 1377–1382
Mi F L, Wu Y B, Shyu S S, et al. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J Biomed Mater Res, 2001, 59: 438–449
Kent M E, Rapp R P, Smith K M. Antibiotic beads and osteomyelitis: Here today, what’s coming tomorrow? Orthopedics, 2006, 29: 599–603
Wenke J C, Owens B D, Svoboda S J, et al. Effectiveness of commercially-available antibiotic-impregnated implants. J Bone Joint Surg Br Vol, 2006, 88: 1102–1104
Anagnostakos K, Hitzler P, Pape D, et al. Persistence of bacterial growth on antibiotic-loaded beads: Is it actually a problem? Acta Orthop, 2008, 79: 302–307
Turner T M, Urban R M, Hall D J, et al. Local and systemic levels of tobramycin delivered from calcium sulfate bone graft substitute pellets. Clin Orthop Rel Res, 2005, 437: 97–104
Cai X, Han K, Cong X, et al. The use of calcium sulfate impregnated with vancomycin in the treatment of open fractures of long bones: A preliminary study. Orthopedics, 2010, 33: 152–157
Helgeson M D, Potter B K, Tucker C J, et al. Antibiotic-impregnated calcium sulfate use in combat-related open fractures. Orthopedics, 2009, 32: 323
Shi M, Kretlow J D, Nguyen A, et al. Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control. Biomaterials, 2010, 31: 4146–4156
Buschle-Diller G, Cooper J, Xie Z, et al. Release of antibiotics from electrospun bicomponent fibers. Cellulose, 2007, 14: 553–562
Özalp Y, Özdemir N, Kocagöz S, et al. Controlled release of vancomycin from biodegradable microcapsules. J Microencapsul, 2001, 18: 89–110
Pillai R R, Somayaji S N, Rabinovich M, et al. Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis. Biomed Mater, 2008, 3: 034114
Ambrose C G, Gogola G R, Clyburn T A, et al. Antibiotic microspheres: Preliminary testing for potential treatment of osteomyelitis. Clin Orthop Rel Res, 2003, 415: 279–285
Ramchandani M, Robinson D. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. J Control Release, 2998, 54: 167–175
Rui J, Dadsetan M, Runge M B, et al. Controlled release of vascular endothelial growth factor using poly-lactic-co-glycolic acid microspheres: In vitro characterization and application in polycaprolactone fumarate nerve conduits. Acta Biomater, 2012, 8: 511–518
Ruhé P Q, Boerman O C, Russel F G, et al. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release, 2005, 106: 162–171
Klasen H J. Historical review of the use of silver in the treatement of burns. I. Early uses. Burns, 2000, 26: 117–130
Huh A J, Kwon Y J. “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotic resistant era. J Control Release, 2011, 156: 128–145
Davis I J, Richards H, Mullany P. Isolation of silver- and antibiotic-resistant Enterobacter cloacae from teeth. Oral Microbiol Immunol, 2005, 20: 191–194
Feng Q L, Wu J, Chen G Q, et al. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater, 2000, 52: 662–668
Gong P, Li H, He X, et al. Preparation and antibacterial activity of Fe3O4@Ag nanoparticles. Nanotechnology, 2007, 18: 285604
Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv, 2009, 27: 76–83
Grewal J S, Tiwari R P. Resistance to metal ions and antibiotics in Escherichia coli isolated from foodstuffs. J Med Microbiol, 1990, 32: 223–226
Choi S, Isaacs A, Clements D, et al. De novo design and in vivo activity of conformationally restrained antimicrobial peptides. Proc Natl Acad Sci USA, 2009, 106: 6968–6973
Liu D, Choi S, Chen B, et al. Nontoxic membrane-active antimicrobial arylamide oligomers. Angew Chem Int Ed, 2004, 43: 1158–1162
Kazemzadeh-Narbat M, Kindrachuk J, Duan K, et al. Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant associated infections. Biomaterials, 2010, 31: 9519–9526
Stallman H P, Faber C, Bronckers A L J J, et al. Osteomyelitis prevention in rabbits using antimicrobial peptide hLF1-11- or gentamicin-containing calcium phosphate cement. J Antimicrob Chemother, 2004, 54: 472–476
Stallman H P, de Roo R, Faber C, et al. In vivo release of the antimicrobial peptide hlf1-11 from calcium phosphate cement. J Orthop Res, 2008, 26: 531–538
Shukla A, Fleming K E, Chuang H F, et al. Controlling the release of peptide antimicrobial agents from surfaces. Biomaterials, 2010, 31: 2348–2357
Zasloff M. Antimicrobial peptides of multicellular origin. Nature, 2002, 415: 389–395
Bell G, Gouyon P H. Arming the enemy: The evolution of resistance development and persistence. Microbiology, 2003, 149: 1367–1375
Perron G G, Zasloff M, Bell G. Experimental evolution of resistance to an antimicrobial peptide. Proc R Soc B-Biol Sci, 2006, 273: 251–256
Anaya-López J L, López-Meza J E, Ochoa-Zarzosa A. Bacterial resistance to cationic antimicrobial peptides. Crit Rev Microbiol, 2012, 38: 1–16
Neut D, van de Belt H, Stokroos I, et al. Biomaterial-associate infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother, 2001, 47: 885–891
Anagnostakos K, Hitzler P, Pape D, et al. Persistence of bacterial growth on antibiotic-loaded beads: Is it actually a problem? Acta Orthop, 2008, 79: 302–307
Olson M E, Ceri H, Morck D W, et al. Biofilm bacteria: Formation and comparative susceptibility to antibiotics. Can J Vet Res, 2002, 66: 86–92
Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov, 2003, 2: 114–122
Kirby A E, Garner K, Levin B R. The relative contributions of physical structure and cell density to the antibiotic susceptibility of bacteria in biofilms. Antimicrob Agents Chemother, 2012, 56: 2967–2975
Davies D G, Marques C N. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol, 2009, 191: 1393–1403
Jennings J A, Courtney H S, Haggard W O. Cis-2-decenoic acid inhibits s. aureus growth and biofilm in vitro: A pilot study. Clin Orthop Rel Res, 2012, 470: 2663–2670
Lü H, Zhang S, Wang B, et al. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release, 2006, 114: 100–109
Nagamune H, Maeda T, Ohkura K, et al. Evaluation of the cytotoxic effects of bis-quaternary ammonium antimicrobial reagents on human cells. Toxicol In Vitro, 2000, 14: 139–147
Cheng G, Xue H, Zhang Z, et al. A switchable biocompatible polymer surface with self-sterilizing and nonfouling capabilities. Angew Chem Int Ed, 2008, 47: 8831–8834
Tan H, Peng Z, Li Q, et al. The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. Biomaterials, 2010, 33: 365–377
Hochbaum A I, Kolodkin-Gal I, Foulston L, et al. Inhibitory effects of D-amino acids on staphylococcus aureus biofilm development. J Bacteriol, 2011, 193: 5616–5622
Kolodkin-Gal I, Romero D, Cao S, et al. D-amino acids trigger biofilm disassembly. Science, 2010, 328: 627–629
Xu H, Liu Y. D-amino acid mitigated membrane biofouling and promoted biofilm detachment. J Membr Sci, 2011, 376: 266–274
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Shah, S.R., Kasper, F.K. & Mikos, A.G. Perspectives on the prevention and treatment of infection for orthopedic tissue engineering applications. Chin. Sci. Bull. 58, 4342–4348 (2013). https://doi.org/10.1007/s11434-013-5780-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-013-5780-8